bluebird bio Statistics
Total Valuation
bluebird bio has a market cap or net worth of $3.59 million. The enterprise value is $3.35 million.
| Market Cap | 3.59M |
| Enterprise Value | 3.35M |
Important Dates
The last earnings date was Thursday, August 28, 2025, after market close.
| Earnings Date | Aug 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
bluebird bio has 97.40 million shares outstanding. The number of shares has increased by 44.02% in one year.
| Current Share Class | 97.40M |
| Shares Outstanding | 97.40M |
| Shares Change (YoY) | +44.02% |
| Shares Change (QoQ) | -15.99% |
| Owned by Insiders (%) | 25.88% |
| Owned by Institutions (%) | 3.99% |
| Float | 65.06M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 0.20 |
| PB Ratio | -44.98 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.06 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.97 |
Financial Position
The company has a current ratio of 0.87
| Current Ratio | 0.87 |
| Quick Ratio | 0.78 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -6,729.39% and return on invested capital (ROIC) is -4,687.94%.
| Return on Equity (ROE) | -6,729.39% |
| Return on Assets (ROA) | -160.13% |
| Return on Invested Capital (ROIC) | -4,687.94% |
| Return on Capital Employed (ROCE) | 1,533.11% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 248 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, bluebird bio has paid $9,481 in taxes.
| Income Tax | 9,481 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -72.49% in the last 52 weeks. The beta is 0.03, so bluebird bio's price volatility has been lower than the market average.
| Beta (5Y) | 0.03 |
| 52-Week Price Change | -72.49% |
| 50-Day Moving Average | 4.42 |
| 200-Day Moving Average | 7.51 |
| Relative Strength Index (RSI) | 62.84 |
| Average Volume (20 Days) | 1,050,643 |
Short Selling Information
The latest short interest is 281,482, so 2.87% of the outstanding shares have been sold short.
| Short Interest | 281,482 |
| Short Previous Month | 428,147 |
| Short % of Shares Out | 2.87% |
| Short % of Float | 2.89% |
| Short Ratio (days to cover) | 0.05 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -1.22M |
| Pretax Income | -1.09M |
| Net Income | -1.10M |
| EBITDA | n/a |
| EBIT | -1.22M |
| Earnings Per Share (EPS) | -$0.02 |
Balance Sheet
The company has $221,221 in cash and n/a in debt, giving a net cash position of $221,221 or $0.00 per share.
| Cash & Cash Equivalents | 221,221 |
| Total Debt | n/a |
| Net Cash | 221,221 |
| Net Cash Per Share | $0.00 |
| Equity (Book Value) | -79,724 |
| Book Value Per Share | -0.00 |
| Working Capital | -79,724 |
Cash Flow
In the last 12 months, operating cash flow was -$1.14 million and capital expenditures $10,436, giving a free cash flow of -$1.13 million.
| Operating Cash Flow | -1.14M |
| Capital Expenditures | 10,436 |
| Free Cash Flow | -1.13M |
| FCF Per Share | -$0.01 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
bluebird bio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -44.02% |
| Shareholder Yield | -44.02% |
| Earnings Yield | -30.58% |
| FCF Yield | -31.52% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | 797.38% |
| Analyst Consensus | Hold |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 48.63% |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 20, 2023. It was a reverse split with a ratio of 0.212766.
| Last Split Date | Jan 20, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.212766 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |